Wong J C, Holland J, Parsons T, Smith A, Williams P
Department of Pharmaceutical Sciences, University of Nottingham, University Park, United Kingdom.
Infect Immun. 1994 Jan;62(1):48-59. doi: 10.1128/iai.62.1.48-59.1994.
Heme can serve Haemophilus influenzae as a source of both essential porphyrin and iron. In extracellular mammalian body fluids neither free heme nor free iron is available, since they are tightly bound to hemopexin and transferrin, respectively. Since H. influenzae grows in the presence of iron-transferrin and heme-hemopexin and is known to express a saturable receptor for transferrin, we investigated the process by which this pathogen acquired heme from hemopexin for use as an iron source. The ability of human and rabbit hemopexin to donate heme as a source of iron to H. influenzae type b strains was demonstrated by plate bioassays. With a dot enzyme assay with biotinylated hemopexin as ligand, H. influenzae bound heme-hemopexin and apo-hemopexin following growth in iron-restricted, but not in iron-sufficient, medium. Competitive binding studies with heme-hemopexin and apo-hemopexin demonstrated saturability of binding. Neither heme, protoporphyrin IX, hemoglobin, nor transferrin blocked the binding of hemopexin to whole cells, demonstrating the specificity of binding. Treatment of whole H. influenzae cells with trypsin abolished binding. Taken together, these observations suggest that H. influenzae type b expresses an outer membrane protein(s) which acts as a receptor for hemopexin and which is regulated by the availability of iron in the growth medium. In iron-restricted media, H. influenzae 706705 and DL42 did not express the 100-kDa hemopexin-binding protein previously reported (M.S. Hanson, S.E. Pelzel, J. Latimer, U. Muller-Eberhard, and E.J. Hansen, Proc. Natl. Acad. Sci. USA 89:1973-1977, 1992). The putative iron-regulated hemopexin receptor was solubilized from cell envelopes of H. influenzae 706705, DL42, and Eagan with the detergent CHAPS (3-[(3-cholamidopropyl)-dimethyl-ammonio]-1-propanesulfonate) and isolated by affinity chromatography on heme-hemopexin-Sepharose 4B. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the proteins bound to the affinity resin revealed three proteins of 29, 38, and 57 kDa, of which the 57- and 29-kDa proteins bound hemopexin after Western blotting (immunoblotting). A monoclonal antibody to the 57-kDa hemopexin-binding protein of 706705 recognized a 57-kDa protein on Western blots of the cell envelope proteins of 706705, DL42, and Eagan; no reaction was observed with the 100-kDa hemopexin-binding protein of DL42. These data suggest that some H. influenzae strains possess at least two hemopexin receptors, the expression of which is determined by the prevailing growth environment.
血红素可为流感嗜血杆菌提供必需的卟啉和铁。在细胞外的哺乳动物体液中,游离血红素和游离铁均不可用,因为它们分别与血红素结合蛋白和转铁蛋白紧密结合。由于流感嗜血杆菌能在转铁蛋白和血红素 - 血红素结合蛋白存在的情况下生长,且已知其表达一种可饱和的转铁蛋白受体,因此我们研究了这种病原体从血红素结合蛋白获取血红素以用作铁源的过程。平板生物测定法证明了人源和兔源血红素结合蛋白作为铁源向b型流感嗜血杆菌菌株提供血红素的能力。在以生物素化血红素结合蛋白为配体的斑点酶测定中,流感嗜血杆菌在铁限制培养基而非铁充足培养基中生长后,能结合血红素 - 血红素结合蛋白和脱辅基血红素结合蛋白。血红素 - 血红素结合蛋白和脱辅基血红素结合蛋白的竞争性结合研究表明结合具有饱和性。血红素、原卟啉IX、血红蛋白和转铁蛋白均未阻断血红素结合蛋白与全细胞的结合,证明了结合的特异性。用胰蛋白酶处理流感嗜血杆菌全细胞可消除结合。综上所述,这些观察结果表明,b型流感嗜血杆菌表达一种外膜蛋白,该蛋白作为血红素结合蛋白的受体,且受生长培养基中铁的可用性调节。在铁限制培养基中,流感嗜血杆菌706705和DL42不表达先前报道的100 kDa血红素结合蛋白(M.S. 汉森、S.E. 佩尔泽尔、J. 拉蒂默、U. 米勒 - 埃伯哈德和E.J. 汉森,《美国国家科学院院刊》89:1973 - 1977, 1992)。用去污剂CHAPS(3 - [(3 - 胆酰胺丙基) - 二甲基 - 铵基] - 1 - 丙烷磺酸盐)从流感嗜血杆菌706705、DL42和伊根的细胞膜中溶解假定的铁调节血红素受体,并通过在血红素 - 血红素结合蛋白 - 琼脂糖4B上的亲和层析进行分离。与亲和树脂结合的蛋白质的十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳显示有三种蛋白质,分子量分别为29 kDa、38 kDa和57 kDa,其中57 kDa和29 kDa的蛋白质在蛋白质印迹(免疫印迹)后能结合血红素结合蛋白。针对706705的57 kDa血红素结合蛋白的单克隆抗体在706705、DL42和伊根的细胞膜蛋白的蛋白质印迹上识别出一种57 kDa的蛋白质;未观察到与DL42的100 kDa血红素结合蛋白发生反应。这些数据表明,一些流感嗜血杆菌菌株至少拥有两种血红素受体,其表达由主要的生长环境决定。